Tech Company Financing Transactions
Sonomind Funding Round
Sonomind secured a $3.5 million funding round on 9/24/2025. Backers included private investors.
Transaction Overview
Company Name
Announced On
9/24/2025
Transaction Type
Venture Equity
Amount
$3,530,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to launch a clinical trial in patients with drug-resistant depression and finalize development of its non-invasive technology.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
Paris, Undisclosed
France
Paris, Undisclosed
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At SONOMIND, we envision a world where mental health issues, including depression, are no longer a losing battle. We envision a world where precision treatments enable fast and effective care, giving every patient a new chance to live life to the fullest. Our team consists of scientists and MedTech experts, each with over 20 years of experience in research and the healthcare industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jérémy Bercoff
Browse more venture capital transactions:
Prev: 9/24/2025: Goodvest venture capital transaction
Next: 9/24/2025: WeTravel venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs